Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
4.720
+0.020 (0.43%)
At close: May 12, 2026, 4:00 PM EDT
4.630
-0.090 (-1.91%)
After-hours: May 12, 2026, 4:54 PM EDT
Bicycle Therapeutics Market Cap
Bicycle Therapeutics has a market cap or net worth of $329.02 million as of May 12, 2026. Its market cap has decreased by -43.58% in one year.
Market Cap
329.02M
Enterprise Value
-285.73M
1-Year Change
-43.58%
Ranking
Category
Stock Price
$4.72
Market Cap Chart
Since May 23, 2019, Bicycle Therapeutics's market cap has increased from $212.36M to $329.02M, an increase of 54.94%. That is a compound annual growth rate of 6.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 327.62M | -33.29% |
| Dec 31, 2025 | 491.12M | -49.19% |
| Dec 31, 2024 | 966.64M | 26.03% |
| Dec 29, 2023 | 766.98M | -12.72% |
| Dec 30, 2022 | 878.81M | -50.89% |
| Dec 31, 2021 | 1.79B | 367.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nautilus Biotechnology | 340.57M |
| DiaMedica Therapeutics | 340.54M |
| Immuneering | 337.72M |
| Replimune Group | 336.07M |
| Abeona Therapeutics | 335.61M |
| Neumora Therapeutics | 334.32M |
| Rezolute | 333.43M |
| Surrozen | 332.66M |